Fenton Mary Kay 4
4 · Cullinan Therapeutics, Inc. · Filed Feb 21, 2025
Insider Transaction Report
Form 4
Fenton Mary Kay
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-19+120,000→ 120,000 totalExercise: $9.43Exp: 2035-02-19→ Common Stock (120,000 underlying) - Award
Common Stock
2025-02-19+60,000→ 60,000 total
Footnotes (2)
- [F1]The shares underlying the restricted stock unit vest on an annual basis over four years.
- [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.